Hussein N. Rubaiy

Leicester, ENG LE39QP, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Attitudes of Swedish primary care physicians toward GLP-1 receptor agonists for overweight and obesity: a cross-sectional survey.

Attitudes of Swedish primary care physicians toward GLP-1 receptor agonists for overweight and obesity: a cross-sectional survey.

Journal: BMC primary care
Published: March 15, 2026

The Concise Guide to PHARMACOLOGY 2025/26: Ion channels.

The Concise Guide to PHARMACOLOGY 2025/26: Ion channels.

Journal: British journal of pharmacology
Published: December 29, 2025

Transient Receptor Potential Canonical Channels in Cardiovascular Pathology and Their Modulators.

Transient Receptor Potential Canonical Channels in Cardiovascular Pathology and Their Modulators.

Journal: Journal of cardiovascular pharmacology
Published: April 23, 2024

ORAI Calcium Channels: Regulation, Function, Pharmacology, and Therapeutic Targets.

ORAI Calcium Channels: Regulation, Function, Pharmacology, and Therapeutic Targets.

Journal: Pharmaceuticals (Basel, Switzerland)
Published: December 27, 2022

Strategies to Inspire Students' Engagement in Pharmacology Courses.

Strategies to Inspire Students' Engagement in Pharmacology Courses.

Journal: Pharmacy (Basel, Switzerland)
Published: February 23, 2021

Kir6.2-D323 and SUR2A-Q1336: an intersubunit interaction pairing for allosteric information transfer in the KATP channel complex.

Kir6.2-D323 and SUR2A-Q1336: an intersubunit interaction pairing for allosteric information transfer in the KATP channel complex.

Journal: The Biochemical journal
Published: October 14, 2019

Mibefradil, a T-type Ca2+ channel blocker also blocks Orai channels by action at the extracellular surface.

Mibefradil, a T-type Ca2+ channel blocker also blocks Orai channels by action at the extracellular surface.

Journal: British journal of pharmacology
Published: October 29, 2018

Treasure troves of pharmacological tools to study transient receptor potential canonical 1/4/5 channels.

Treasure troves of pharmacological tools to study transient receptor potential canonical 1/4/5 channels.

Journal: British journal of pharmacology
Published: October 17, 2018

Tonantzitlolone is a nanomolar potency activator of transient receptor potential canonical 1/4/5 channels.

Tonantzitlolone is a nanomolar potency activator of transient receptor potential canonical 1/4/5 channels.

Journal: British journal of pharmacology
Published: May 15, 2018

Remarkable Progress with Small-Molecule Modulation of TRPC1/4/5 Channels: Implications for Understanding the Channels in Health and Disease.

Remarkable Progress with Small-Molecule Modulation of TRPC1/4/5 Channels: Implications for Understanding the Channels in Health and Disease.

Journal: Cells
Published: April 27, 2018

TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A.

TRPC4/TRPC5 channels mediate adverse reaction to the cancer cell cytotoxic agent (-)-Englerin A.

Journal: Oncotarget
Published: September 29, 2017

Identification of an (-)-englerin A analogue, which antagonizes (-)-englerin A at TRPC1/4/5 channels.

Identification of an (-)-englerin A analogue, which antagonizes (-)-englerin A at TRPC1/4/5 channels.

Journal: British journal of pharmacology
Published: June 12, 2017
Showing 1-12 of 19

Last Updated: 09/26/2026